Shirin Ardeshir-Rouhani-Fard

发表

Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity

R. Frisina, N. Cox, E. Gamazon, 2016, Clinical Cancer Research.

Lack of association of genetic polymorphisms of angiotensin converting enzyme 1 and angiotensin II type 1 receptor with breast cancer risk in Iranian population

Shirin Ardeshir-Rouhani-Fard, A. Monabati, N. Azarpira, 2013, Tumor Biology.

Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in iranian population

Shirin Ardeshir-Rouhani-Fard, A. Monabati, N. Azarpira, 2010, Molecular carcinogenesis.

Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.

S. Fosså, H. Sesso, D. Feldman, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

The effect of renin angiotensin system on tamoxifen resistance.

Shirin Ardeshir-Rouhani-Fard, S. Namazi, H. Abedtash, 2011, Medical hypotheses.

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.

R. Frisina, S. Fosså, M. Dolan, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms

R. Frisina, E. Gamazon, S. Fosså, 2019, Clinical Cancer Research.

The impact of renin-angiotensin system, angiotensin І converting enzyme (insertion/deletion), and angiotensin ІІ type 1 receptor (A1166C) polymorphisms on breast cancer survival in Iran.

Shirin Ardeshir-Rouhani-Fard, M. Mohammadianpanah, P. Jafari, 2013, Gene.

Essential oil composition and bioinformatic analysis of Spanish broom (Spartium junceum L.)

Mohammad Hossein Morowvat, Y. Ghasemi, Shirin Ardeshir-Rouhani-Fard, 2015 .

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

E. Gamazon, S. Fosså, M. Dolan, 2017, Clinical Cancer Research.

Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors

S. Fosså, C. Fung, Shirin Ardeshir-Rouhani-Fard, 2018, Advances in urology.

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

S. Fosså, H. Sesso, S. Lipshultz, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy

Frederick G. Strathmann, S. Fosså, M. Dolan, 2019, Clinical Cancer Research.

Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors

R. Frisina, S. Fosså, R. Huddart, 2020, JNCI cancer spectrum.

Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.

S. Fosså, M. Dolan, R. Huddart, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

S. Fosså, R. Huddart, H. Sesso, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin‐based Chemotherapy: Application of the Framingham Risk Score

R. Frisina, S. Fosså, M. Dolan, 2018, Clinical genitourinary cancer.

Residual Platinum Concentrations in Post-Cancer Chemotherapy and Healthy Control Populations Using an Automated, 96-Well Plate Method and Inductively Coupled Plasma Mass Spectrometry.

Frederick G. Strathmann, S. Fosså, Shirin Ardeshir-Rouhani-Fard, 2016, The journal of applied laboratory medicine.

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

S. Fosså, R. Huddart, H. Sesso, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adverse health outcomes in relationship to hypogonadism (HG) after platinum-based chemotherapy: A multicenter study of North American testicular cancer survivors (TCS).

S. Fosså, H. Sesso, D. Feldman, 2017 .

Clinical, sociodemographic, and behavioral factors associated with cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study.

S. Fosså, R. Huddart, H. Sesso, 2017 .